Literature DB >> 17064277

Adherence of Abiotrophia defectiva and Granulicatella species to fibronectin: is there a link with endovascular infections?

Laurence Senn1, José M Entenza, Guy Prod'hom.   

Abstract

During a 6-year period, we isolated three Abiotrophia defectiva, six Granulicatella adiacens and two G. 'para-adiacens' strains from clinical specimens. All A. defectiva strains were isolated from immunocompetent patients with endovascular infections, whereas the Granulicatella spp. strains were isolated from immunosuppressed patients with primary bacteremia. As the capacity of bacteria to adhere to the host extracellular matrix (ECM) has been implicated in the pathogenesis of endovascular infection, we investigated the ability of A. defectiva and Granulicatella spp. isolates to bind different ECM components immobilized in microtiter plates. Adherence tests showed a strong attachment of A. defectiva strains to fibronectin, whereas Granulicatella spp. strains were not adherent. The poor adherence of Granulicatella spp. strains to the ECM could be correlated with a lower propensity to induce endocarditis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17064277     DOI: 10.1111/j.1574-695X.2006.00142.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  3 in total

1.  Abiotrophia defectiva endophthalmitis following routine cataract surgery: the first reported case in the United Kingdom.

Authors:  Madalina Chihaia; James Richardson-May; Layth Al-Saffar; Hiron Kettledas; Mohammed Rashid
Journal:  Access Microbiol       Date:  2020-03-23

Review 2.  Microbiology of odontogenic bacteremia: beyond endocarditis.

Authors:  N B Parahitiyawa; L J Jin; W K Leung; W C Yam; L P Samaranayake
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

3.  Successful treatment of periprosthetic joint infection caused by Granulicatella para-adiacens with prosthesis retention: a case report.

Authors:  Nora Renz; Fabienne Chevaux; Olivier Borens; Andrej Trampuz
Journal:  BMC Musculoskelet Disord       Date:  2016-04-12       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.